APPLICATION
ANDA074805
TYPE
ANDA
ORIGINAL APPROVAL
2002-02-20
LATEST ACTION
2024-12-12
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Prescription
Products
FLUNISOLIDEPrescription
FLUNISOLIDE 0.025MG/SPRAY · SPRAY, METERED · NASAL
Approval history
2024-12-12Manufacturing (CMC) · Supplement 22 · unknownAP
2004-05-18Labeling · Supplement 3AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.